Scott M. Coiante - 25 Aug 2021 Form 4 Insider Report for Aprea Therapeutics, Inc. (APRE)

Role
SVP, Chief Financial Officer
Signature
/s/ Scott M. Coiante
Issuer symbol
APRE
Transactions as of
25 Aug 2021
Net transactions value
-$29,985
Form type
4
Filing time
27 Aug 2021, 17:01:25 UTC
Next filing
01 Mar 2022
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction APRE Common Stock Tax liability $29,985 -7,534 -7.6% $3.98 91,466 25 Aug 2021 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents shares withheld to satisfy tax withholding obligations in connection with the vesting of 21,166 restricted stock units.